Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-07-20
1991-01-01
Rivers, Diana G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
548101, 548104, A61K 31555, C07F 306, C07D22364
Patent
active
049818465
ABSTRACT:
A novel crystalline L-carnosine zinc complex is produced by reacting L-carnosine, a zinc salt and an alkali metal compound in an anhydrous or hydrous polar organic solvent.
The crystalline L-carnosine zinc complex substantially corresponds to the formula C.sub.9 H.sub.12 N.sub.4 O.sub.3 Zn and has physical properties clearly different from the known amorphous L-carnosine zinc complex.
As compared with the amorphous complex, the crystalline complex is very low in impurity, stable to heat and moisture, and easy to filtrate, and has higher anti-ulcer activity.
REFERENCES:
Weitzel et al., Hoppe-S-Z. Physiol. Chem., 307, 23, (1957).
Fujimura Hajime
Matsukura Takefumi
Nishimura Yasuhiro
Takahashi Tamiko
Takaya Masahiro
Hamari Chemicals Ltd.
Rivers Diana G.
LandOfFree
Crystalline L-carnosine zinc complex having antiulcer activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline L-carnosine zinc complex having antiulcer activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline L-carnosine zinc complex having antiulcer activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1996380